AHA GUIDELINES Bundle (free trial)

High Blood Pressure - Merck Supported

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1539869

Contents of this Issue

Navigation

Page 26 of 87

27 Table 11. Selected List of Frequently Used Medications and Other Substances That May Cause Elevated Blood Pressure With Recommendations for Management* (cont'd) Agent Possible Management Strategy Prescription drugs (cont'd) Atypical antipsychotics † (eg, risperidone, olanzapine) Discontinue or limit use when possible Consider behavior therapy where appropriate Recommend lifestyle modification (Section 5.1) Consider alternative agents associated with lower risk of weight gain, diabetes, and dyslipidemia Immunosuppressants † (eg, cyclosporine) Consider converting to tacrolimus, which may be associated with fewer effects on BP Oral contraceptives † Use low-dose (eg, 20–30 mcg ethinyl estradiol) agents or a progestin-only form of contraception, or consider alternative forms of birth control where appropriate (eg, barrier, abstinence, nonhormonal IUD) Avoid use in women with uncontrolled hypertension Systemic corticosteroids † (eg, dexamethasone, fludrocortisone, methylprednisolone, prednisone, prednisolone) Avoid or limit use when possible Consider alternative modes of administration (eg, inhaled, topical) when feasible Angiogenesis inhibitor † (eg, bevacizumab) and tyrosine kinase inhibitors (eg, sunitinib, sorafenib) Avoid or limit use when possible Androgen deprivation therapy † such as CYP 17 inhibitors (eg, abiraterone, orteronel) or androgen receptor antagonist (eg, enzalutamide) Avoid or limit use when possible Consider alternative chemotherapy * List is not all inclusive. † In specific cases when a specific therapy is needed or the best option for the patient, it is reasonable to continue the medication and initiate or intensify antihypertensive therapy. ADHD indicates attention-deficit/hyperactivity disorder; IUD, intrauterine device; MAOI, monoamine-oxidase inhibitors; MDPV, methylenedioxy pyrovalerone; SNRI, serotonin norepinephrine-reuptake inhibitor; SSRI, selective serotonin-reuptake inhibitor; and TCA, tricyclic antidepressant. Modified with permission from Whelton et al. Copyright © 2018 American College of Cardiology Foundation and American Heart Association, Inc.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - High Blood Pressure - Merck Supported